Gossamer Bio Inc (GOSS) Implied Volatility Current

Tracking GOSS implied volatility helps you identify when options premiums on Gossamer Bio Inc are historically cheap or expensive, and where the best trades are hiding. Gossamer Bio Inc implied volatility reflects the market's expectation of future price movement: when GOSS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Gossamer Bio Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For GOSS, tracking metrics like GOSS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on GOSS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis.

It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where GOSS implied volatility sits today versus where it has been. Our scanner ranks Gossamer Bio Inc implied volatility against its historical range, surfaces extremes in GOSS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Gossamer Bio Inc IV is rich or cheap — measure it, then act on it.